Last reviewed · How we verify

Tong-Luo-Qu-Tong Plaster — Competitive Intelligence Brief

Tong-Luo-Qu-Tong Plaster (Tong-Luo-Qu-Tong Plaster) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Pain management.

phase 3 Traditional Chinese medicine Pain management Small molecule Live · refreshed every 30 min

Target snapshot

Tong-Luo-Qu-Tong Plaster (Tong-Luo-Qu-Tong Plaster) — Shanghai University of Traditional Chinese Medicine. Tong-Luo-Qu-Tong Plaster is a traditional Chinese medicine used to relieve pain and reduce inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Tong-Luo-Qu-Tong Plaster TARGET Tong-Luo-Qu-Tong Plaster Shanghai University of Traditional Chinese Medicine phase 3 Traditional Chinese medicine
Placebo of Gastrodia and Uncaria granule Placebo of Gastrodia and Uncaria granule Shanghai Institute of Hypertension marketed Herbal medicine / Traditional Chinese medicine
Sanjin tablets simulants Sanjin tablets simulants China Academy of Chinese Medical Sciences marketed Traditional Chinese medicine
Abelmoschus manihot (AM) Abelmoschus manihot (AM) Chinese PLA General Hospital marketed Herbal extract / Traditional Chinese Medicine
Xingnaojing injection + Shuxuetong oral liquid Xingnaojing injection + Shuxuetong oral liquid Peking University Third Hospital marketed Traditional Chinese medicine combination / Herbal extract
Entecavir+Fuzheng Huayu+TCM Granule Entecavir+Fuzheng Huayu+TCM Granule ShuGuang Hospital marketed Nucleoside reverse transcriptase inhibitor + Traditional Chinese Medicine herbal combination HBV reverse transcriptase (entecavir component); multiple herbal constituents with unclear specific molecular targets
Jinlida granules Jinlida granules Shanghai Jiao Tong University School of Medicine marketed Traditional Chinese medicine herbal formulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

  1. Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
  2. Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
  3. Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
  4. Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
  5. Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
  6. China Academy of Chinese Medical Sciences · 1 drug in this class
  7. The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
  8. Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tong-Luo-Qu-Tong Plaster — Competitive Intelligence Brief. https://druglandscape.com/ci/tong-luo-qu-tong-plaster. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: